These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10590087)

  • 21. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.
    Keelapang P; Sriburi R; Supasa S; Panyadee N; Songjaeng A; Jairungsri A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol; 2004 Mar; 78(5):2367-81. PubMed ID: 14963133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junín virus envelope glycoprotein.
    York J; Nunberg JH
    Virology; 2007 Mar; 359(1):72-81. PubMed ID: 17045626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.
    Schlesinger JJ; Chapman S; Nestorowicz A; Rice CM; Ginocchio TE; Chambers TJ
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1277-85. PubMed ID: 8683217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.
    Nickells M; Chambers TJ
    J Virol; 2003 Nov; 77(22):12232-42. PubMed ID: 14581560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.
    Vlaycheva L; Nickells M; Droll DA; Chambers TJ
    Virology; 2004 Sep; 327(1):41-9. PubMed ID: 15327896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid substitution(s) in the stem-anchor region of langat virus envelope protein attenuates mouse neurovirulence.
    Holbrook MR; Ni H; Shope RE; Barrett AD
    Virology; 2001 Jul; 286(1):54-61. PubMed ID: 11448158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.
    Kümmerer BM; Rice CM
    J Virol; 2002 May; 76(10):4773-84. PubMed ID: 11967294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro processing of dengue virus structural proteins: cleavage of the pre-membrane protein.
    Markoff L
    J Virol; 1989 Aug; 63(8):3345-52. PubMed ID: 2501515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a dominant endoplasmic reticulum-retention signal in yellow fever virus pre-membrane protein.
    Ciczora Y; Callens N; Séron K; Rouillé Y; Dubuisson J
    J Gen Virol; 2010 Feb; 91(Pt 2):404-14. PubMed ID: 19846669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranslational signal peptidase cleavage at the flavivirus C-prM junction in vitro.
    Stocks CE; Lobigs M
    J Virol; 1995 Dec; 69(12):8123-6. PubMed ID: 7494334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Processing of dengue virus type 2 structural proteins containing deletions in hydrophobic domains.
    Gruenberg A; Wright PJ
    Arch Virol; 1992; 122(1-2):77-94. PubMed ID: 1729986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera.
    Chambers TJ; McCourt DW; Rice CM
    Virology; 1990 Jul; 177(1):159-74. PubMed ID: 2353452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase.
    Hüssy P; Langen H; Mous J; Jacobsen H
    Virology; 1996 Oct; 224(1):93-104. PubMed ID: 8862403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
    Shao J; Liu X; Ly H; Liang Y
    J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifications to the Foot-and-Mouth Disease Virus 2A Peptide: Influence on Polyprotein Processing and Virus Replication.
    Kjær J; Belsham GJ
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.